Dr Reddy's Laboratories (Dr Reddy's Laboratories) PB Ratio : 3.84 (As of Apr. 25, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Dr Reddy's Laboratories PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-25), Dr Reddy's Laboratories's share price is $74.16. Dr Reddy's Laboratories's Book Value per Share for the quarter that ended in Dec. 2023 was $19.32. Hence, Dr Reddy's Laboratories's PB Ratio of today is 3.84.

The historical rank and industry rank for Dr Reddy's Laboratories's PB Ratio or its related term are showing as below:

RDY' s PB Ratio Range Over the Past 10 Years
Min: 2.55 Med: 3.97 Max: 6.2
Current: 3.87

During the past 13 years, Dr Reddy's Laboratories's highest PB Ratio was 6.20. The lowest was 2.55. And the median was 3.97.

RDY's PB Ratio is ranked worse than
76.92% of 962 companies
in the Drug Manufacturers industry
Industry Median: 1.945 vs RDY: 3.87

During the past 12 months, Dr Reddy's Laboratories's average Book Value Per Share Growth Rate was 21.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 14.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 12.20% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 10.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Dr Reddy's Laboratories was 59.20% per year. The lowest was -1.20% per year. And the median was 11.50% per year.

Back to Basics: PB Ratio

Dr Reddy's Laboratories PB Ratio Historical Data

The historical data trend for Dr Reddy's Laboratories's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories PB Ratio Chart

Dr Reddy's Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

PB Ratio

Get a 7-Day Free Trial

3.33

3.22

4.28

3.70

3.37

Dr Reddy's Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
PB Ratio	Get a 7-Day Free Trial															3.22	3.37	3.52	3.65	3.60

Competitive Comparison of Dr Reddy's Laboratories's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Reddy's Laboratories's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's PB Ratio distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's PB Ratio falls into.

Dr Reddy's Laboratories PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Dr Reddy's Laboratories's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	74.16	/	19.321
	=	3.84

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Dr Reddy's Laboratories (NYSE:RDY) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Dr Reddy's Laboratories PB Ratio Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories (Dr Reddy's Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NYSE:RDY) » Definitions » PB Ratio

Traded in Other Exchanges

DRREDDY:India 500124:India RDDA:Germany RDDA:Germany R1DY34:Brazil

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.